Jacquelyn A. Hedlund MD

Physician

100 Campus DriveSuite 108Scarborough, ME 04074
Phone+1 207-396-7600
Fax+1 207-396-7986

Dr. Hedlund is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hedlund's full profile Already have an account?

Education & Training

University of Washington School of MedicineFellowship, Blood Banking/Transfusion Medicine, 1995 - 1996
University of WashingtonFellowship, Hematology and Medical Oncology, 1994 - 1995
MaineHealthResidency, Internal Medicine, 1990 - 1994
University of Vermont College of MedicineClass of 1990

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2015 - 2027
ME State Medical License 1993 - 2027
FL State Medical License 2020 - 2026
MS State Medical License 2017 - 2024
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2012, 2014-2016
CMS Meaningful Use Stage 1 Certification OncoEMR, Flatiron Health, Inc., 2012, 2014-2016
CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2012, 2014-2016

Clinical Trials

Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
UNKNOWN
PHASE1, PHASE2
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant Start of enrollment: 2013 May 16
COMPLETED
PHASE1

Publications & Presentations

PubMed

32 citations
A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma
Jacob P. Laubach, Chia Jen Liu, Noopur Raje, Andrew Yee, Philippe Armand
Clinical Cancer Research. 2019-01-15
12 citations
Herpes simplex encephalitis as a complication of whole-brain radiotherapy: a case report and review of the literature.
David J Sermer, Jamie L Woodley, Christian A Thomas, Jacquelyn A Hedlund
Case Reports in Oncology. 2014-11-21
31 citations
Attenuating homologous recombination stimulates an AID-induced antileukemic effect.
Kristin Lamont, Muneer G. Hasham, Nina M Donghia, Jane Branca, Margaret Chavaree
The Journal of Experimental Medicine. 2013-05-06